Skip to main navigation menu Skip to main content Skip to site footer

No. 4 (2024)

PRACTICE

Actual Problems of Diagnosis and Therapy of Obsessive-Compulsive Disorder

https://doi.org/10.21265/PSYPH.2024.82.91.007

Published 2024-12-30

  • D.S. Petelin
    • ,
  • A.S. Avedisova
    • ,
  • D.V. Ivashchenko
    • ,
  • V.E. Medvedev
    • ,
  • V.D. Mendelevich
    • ,
  • Yu.P. Sivolap
    • ,
  • G.M. Usov

D.S. Petelin
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia

A.S. Avedisova
V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, Ministry of Health of Russia; Z.P. Solovyov Scientific and Practical Psychoneurological Center of the Moscow City Health Department

D.V. Ivashchenko
Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

V.E. Medvedev
Peoples' Friendship University of Russia (RUDN University)

V.D. Mendelevich
Kazan State Medical University, Ministry of Health of Russia

Yu.P. Sivolap
Peoples' Friendship University of Russia (RUDN University)

G.M. Usov
Omsk State Medical University, Ministry of Health of the Russia

Abstract

Obsessive-compulsive disorder (OCD) is a common and poorly diagnosed disorder that has a significant negative impact on the functioning and quality of life of the patients. There are a number of controversial issues regarding the diagnosis and treatment of OCD that have not yet been fully resolved. This publication discusses the diagnostic boundaries of OCD and OCD spectrum disorders, differential diagnosis, and modern approaches to OCD treatment based on the principles of evidence-based medicine. The data on all the main therapeutic approaches are presented – psychopharmacotherapy, psychotherapy, non-drug biological methods of therapy. The use of selective serotonin reuptake inhibitors as the first line of therapy for OCD is substantiated. In conclusion, the publication summarizes the main errors and difficulties associated with the management of patients suffering from obsessive-compulsive disorder.

Keywords

obsessive-compulsive disorder, obsessive-compulsive spectrum, psychopharmacotherapy, psychotherapy, selective serotonin reuptake inhibitors, cognitive behavioral therapy

PDF (Русский)

References

  1. Глава 06. Психические и поведенческие расстройства и нарушения нейропсихического развития. Статистическая классификация // МКБ-11. – М.: КДУ; Университетская книга, 2021. – 432 с. – https://doi.org/10.31453/kdu.ru.91304.0143
  2. Kessler R.C. Psychiatric epidemiology: selected recent advances and future directions // Bulletin of the World Health Organization. – 2000. – Vol. 78 (4). – Pp. 464–474.
  3. Ruscio A.M., Stein D.J., Chiu W.T., Kessler R.C. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication // Molecular Psychiatry. – 2010. – Vol. 15 (1). – Pp. 53–63. – https://doi.org/10.1038/mp.2008.94
  4. Чуркин А.А., Творогова Н.А. Распространенность психических расстройств в Российской Федерации в 2008 г. // Российский психиатрический журнал. – 2009. – № 4. С. 35–40. – URL: https://cyberleninka.ru/article/n/rasprostranennost-psihicheskih-rasstroystv-v-rossiyskoy-federatsii-v-2008-g (дата обращения 04.09.2024)
  5. Stein D.J., Costa D.L.C., Lochner C. et al. Obsessive-compulsive disorder // Nature reviews. Disease primers. – 2019. – Vol. 5 (1). – Art. 52. – https://doi.org/10.1038/s41572-019-0102-3
  6. Незнанов Н.Г., Мартынихин И.А., Мосолов С.Н. Диагностика и терапия тревожных расстройств в Российской Федерации: результаты опроса врачей психиатров // Современная терапия психических расстройств. – 2017. – № 2. – С. https://doi.org/10.21265/PSYPH.2017.41.6437
  7. Менделевич В.Д., Каток А.А., Бейбалаева Т.З., Капралов А.А., Абакаров Р.Р. Диссоциация, «ОКР наоборот» и несостоявшаяся шизофрения. Случай Алсу Б. // Неврологический вестник. – 2023. – Т. LV, № 4. – C. 35–4 https://doi.org/10.17816/nb624043
  8. Osland S., Arnold P.D., Pringsheim T. The prevalence of diagnosed obsessive compulsive disorder and associated comorbidities: A population-based Canadian study. Psychiatry research. – 2018. – Vol. 268. – Pp. 137–142. – https://doi.org/10.1016/j.psychres.2018.07.018
  9. Karno M., Golding J. Obsessive-compulsive disorder. Inpsychiatric disorders in America: the Epidemiologic catchment area study. L.N. Robins and D.A. Regier (eds). – New York: Free Press, 1990. – Pp. 204–219.
  10. Kochar N., Ip S., Vardanega V. et al. A cost-of-illness analysis of the economic burden of obsessive-compulsive disorder in the United Kingdom // Comprehensive Psychiatry. – 2023. – Vol. 127. – Art. 152422. – https://doi.org/10.1016/j.comppsych.2023.152422
  11. Менделевич В.Д. МКБ-11 (психиатрический раздел): кто лучше диагностирует — то лучше лечит? // Неврологический вестник. – 2022. – Т. LIV, № 3. – С. 5–10. https://doi.org/10.17816/nb108994
  12. Сиволап Ю.П., Портнова А.А. МКБ-11: рутинный диагностический инструмент без сияния классической психопатологии прошлого // Неврологический вестник. – 202 Т. LIV, № 3. – C. 96–101. – https://doi.org/10.17816/nb109313
  13. Петелин Д.С., Гамирова А.Н., Сорокина О.Ю. и др. Диагностика и терапия расстройств обсессивно-компульсивного спектра в общемедицинской и неврологической практик Неврология, нейропсихиатрия, психосоматика. – 2023. – № 15 (2). – C. 98–105. – https://doi.org/10.14412/2074-2711-2023-2-98-105
  14. Менделевич В.Д., Габутдинов К.А., Руженкова В.В. Хординг (патологическое накопительство): новый диагноз против традиционной интерпретации. Случай Артёма Л. Неврологический вестник. – 2023. – Т. LV, № 1. – C. 65–78. – https://doi.org/10.17816/nb262939
  15. Медведев В.Э. Дисморфическое расстройство: клиническая и нозологическая гетерогенность // Неврология, нейропсихиатрия, психосоматика. – 2016. – T. 8, № 1. С. 49–55. – https://doi.org/10.14412/2074-2711-2016-1-49-55
  16. Медведев В.Э. Дисморфическое расстройство: гетерогенные факторы риска и клинико-динамические характеристики // Психиатрия и психофармакотерапия. – 2021. № 2. – С. 29–36.
  17. Hollander E., Kwon J.H., Stein D.J. et al. Obsessive-compulsive and spectrum disorders: overview and quality of life issues // The Journal of Clinical Psychiatry. – 1996. – Vol. 57 (8). – Pp. 3–6.
  18. Costa D.L. da C., de Campos A.P., Pereira C.A. de B. et al. Latency to treatment seeking in patients with obsessive-compulsive disorder: Results from a large multicenter clinical sample // Psychiatry Research. – 2022. – Vol. 312. – Art. 114567. – https://doi.org/10.1016/j.psychres.2022.114567
  19. Perez M.I., Limon D.L., Candelari A.E. et al. Obsessive-compulsive disorder misdiagnosis among mental healthcare providers in Latin America // Journal of Obsessive-Compulsive and Related Disorders. – 2022. – Vol. 32. – Art. 100693. – https://doi.org/10.1016/j.jocrd.2021.100693
  20. Fenske J.N., Petersen K. Obsessive-compulsive disorder: Diagnosis and management // American family physician. – 2015. – Vol. 92 (10). – Pp. 896–903.
  21. Goodman W.K. et al. The Yale-Brown Obsessive-Compulsive Scale. II. Validity // Archives of General Psychiatry. – 1989. – Vol. 46 (11). – Pp. 1012–1016. – https://doi.org/10.1001/archpsyc.1989.01810110054008
  22. Katzman M.A., Bleau P., the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders // BMC Psychiatry. – 2014. – Vol. 14 (1). – Art. S1. – https://doi.org/10.1186/1471-244X-14-S1-S1
  23. Virtanen S., Kuja-Halkola, R., Sidorchuk, A. et al. Association of obsessive-compulsive disorder and obsessive-compulsive symptoms with substance misuse in 2 longitudinal cohorts in Sweden // JAMA Network Open. – 2022. – Vol. 5 (6). – e2214779. – https://doi.org/10.1001/jamanetworkopen.2022.14779
  24. Domingues-Castro M.S. et. al. Bipolar disorder comorbidity in patients with obsessive-compulsive disorder: Prevalence and predictors // Journal of Affective Disorders. – 2019. – Vol. 256. – Pp. 324–330. – https://doi.org/10.1016/j.jad.2019.06.018
  25. Mosolov S.N., Ushkalova A.V., Kostukova E.G. et al. Validation of the Russian version of the hypomania checklist (HCL-32) for the detection of bipolar II disorder in patients with a current diagnosis of recurrent depression // Journal of Affective Disorders. – 2014. – Vol. 155. – Pp. 90–95. – https://doi.org/10.1016/j.jad.2013.10.029
  26. de Filippis R., Aguglia A., Costanza A. et al. Obsessive-compulsive disorder as an epiphenomenon of comorbid bipolar disorder? An updated systematic review // Journal of clinical medicine. – 2024. – Vol. 13 (5). – Art. 1230. – https://doi.org/10.3390/jcm13051230
  27. Swets M., Dekker J., van Emmerik-van Oortmerssen K., Smid G.E., Smit F., de Haan L. et al. The obsessive compulsive spectrum in schizophrenia, a meta-analysis and metaregression exploring prevalence rates // Schizophrenia Research. – 2014. – Vol. 152. – Pp. 458–468. – https://doi.org/10.1016/j.schres.2013.10.033
  28. Sharma L.P., Reddy Y.C.J. Obsessive-compulsive disorder comorbid with schizophrenia and bipolar disorder // Indian Journal of Psychiatry. – 2019. – Vol. 61(1). – Pp. S140– S148. – https://doi.org/10.4103/psychiatry.IndianJPsychiatry_527_18
  29. Андриенко Е.В., Мосолова Е.С. Обсессивно-компульсивная симптоматика, индуцированная применением клозапина (алгоритм коррекции) // Современная терапия психических расстройств. – 2023. – № 3. – С. 2 https://doi.org/10.21265/PSYPH.2023.46.45.003
  30. Rasmussen S.A., Eisen J.L. The epidemiology and differential diagnosis of obsessive compulsive disorder // The Journal of clinical psychiatry. – 1992. – Vol. 53. – Pp. 4–10.
  31. Мосолов С.Н. Обсессивно-компульсивное расстройство (диагностика, клиника, терапия): монография. – М.: БИНОМ. Лаборатория знаний, 2005. – 56 с.
  32. Paula-Pérez I. Differential diagnosis between obsessive compulsive disorder and restrictive and repetitive behavioural patterns, activities and interests in autism spectrum disorders // Revista de Psiquiatria y Salud Mental. – 2013. – Vol. 6 (4). – Pp. 178–186. – https://doi.org/10.1016/j.rpsm.2012.07.005
  33. Сиволап Ю.П. Паническое расстройство: клинические феномены и возможности терапии // Журнал неврологии и психиатрии имени С.С. Корсакова. – 2017. – T. (4). – С. 112–116.
  34. Piccinelli M., Pini S., Bellantuono C., Wilkinson G. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review // The British Journal of Psychiatry: the Journal of Mental Science. – 1995. – Vol. 166 (4). – Pp. 424–443. – https://doi.org/10.1192/bjp.166.4.424
  35. Bandelow B., Allgulander C., Baldwin D.S. et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders — Version 3. Part I: Anxiety disorders // The World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry. – 2023. – Vol. 24 (2). – Pp. 79–117. – https://doi.org/10.1080/15622975.2022.2086295
  36. Mundo E., Rouillon F., Figuera M.L., Stigler M. Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine // Human psychopharmacology. – 2001. – Vol. 16 (6). – Pp. 461–468. – https://doi.org/10.1002/hup.317
  37. Karameh W.K., Khani M. Intravenous Clomipramine for treatment-resistant obsessive-compulsive disorder [published correction appears in The International Journal of Neuro-psychopharmacology. – 2016. – Vol. 19 (10). – pyw031. https://doi.org/10.1093/ijnp/pyw031] // The International Journal of Neuropsychopharmacology. – 2015. – Vol. 19 (2). – pyv084. – https://doi.org/10.1093/ijnp/pyv084
  38. Bloch M.H., McGuire J., Landeros-Weisenberger A., Leckman J.F., Pittenger C. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder // Molecular Psychiatry. – 2010. – Vol. 15 (8). – Pp. 850–855. – https://doi.org/10.1038/mp.2009.50
  39. American Psychiatric Association (APA). Practice guideline for obsessive-compulsive disorder, 2007. – Available at: https://psychia-tryonline.org/guideline (accessed October 4, 2024).
  40. Российское общество психиатров. Клинические рекомендации. Обсессивно-компульсивное расстройство, 2019. – URL: https://psychiatr.ru/download/4318?view=1&nme=%D0%9A%D0%A0+%D0%9E%D0%9A%D0%A0.pdf (accessed October 4, 2024).
  41. Ninanß P.T., Koran L.M., Kiev A. et al. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial // The Journal of Clinical Psychiatry. – 2006. – Vol. 67 (1). – Pp. 15–22. – https://doi.org/10.4088/jcp.v67n0103
  42. Issari Y. et al. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis // The Journal of Clinical Psychiatry. – 2016. – Vol. 77 (5). – Pp. e605–e611.
  43. Brar J., Sidana A., Chauhan N., Bajaj M.K. Effect of sertraline and fluvoxamine on quality of life in patients with obsessive-compulsive disorder: A 12-week interventional study // Industrial Psychiatry Journal. – 2022. – Vol. 31 (1). – Pp. 26–30. – https://doi.org/10.4103/ipj.ipj_133_21
  44. Аведисова А.С., Ахапкин Р.В. Проблемы клинической оценки переносимости терапии психотропными препаратами // Психиатрия и психофармакотерапия. – 2005. – Т. 7, № 1. – С. 17–20.
  45. Niarchou E., Roberts L.H., Naughton B.D. What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review // Journal of Psychopharmacology. – 2024. – Vol. 38 (2). – Pp. 127– 136. – https://doi.org/10.1177/02698811231224171
  46. Edinoff A.N., Akuly H.A., Hanna T.A. et al. Selective Serotonin reuptake inhibitors and adverse effects: A narrative review // Neurology International. – 2021. – Vol. 13 (3). – Pp. 387–401. – https://doi.org/10.3390/neurolint13030038
  47. Салахова А.И., Ягубов М.И. Сексуальная дисфункция при применении антидепрессантов у пациентов с тревожными и депрессивными расстройствами (алгоритм ведения и коррекции) // Современная терапия психических расстройств. – 2024. – № 2. – С. 56–67. – https://doi.org/10.21265/PSYPH.2024.31.31.006
  48. Аведисова А.С. Побочные эффекты антидепрессантов, нарушающие сексуальные функции // Психиатрия и психофармакотерапия. – 2005. – Т. 7, № 6. – С. 322–329.
  49. Serretti A., Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis // Journal of Clinical Psychopharmacology. – 2009. – Vol. 29 (3). – Pp. 259–266. – https://doi.org/10.1097/JCP.0b013e3181a5233f
  50. Kasper S., Heiden A. Do SSRIs differ in their antidepressant efficacy // Human psychopharmacology. – 1996. – Vol. 10 (3). – Pp. S163–S172. – https://doi.org/10.1002/hup.470100905
  51. Sunami E., Usuda K., Nishiyama Y., Otori T., Katsura K., Katayama Y. A Preliminary study of Fluvoxamine Maleate on depressive state and Serum Melatonin levels in patients after cerebral infarction // Internal Medicine. – 2012. – Vol. 51 (10). – Pp. 1187–1193. – https://doi.org/10.2169/internalmedicine.51.6699
  52. Hao Y., et al. The Effect of fluvoxamine on sleep architecture of depressed patients with insomnia: An 8-week, open-label, baseline-controlled study // Nature and Science of Sleep. – 2019. – Vol. 11. – Pp. 291–300. – https://doi.org/10.2147/NSS.S220947.
  53. Pompili M., Serafini G., Innamorati M. et al. Antidepressants and suicide risk: A comprehensive overview // Pharmaceuticals (Basel). – 2010. – Vol. 3 (9). – Pp. 2861–2883. – https://doi.org/10.3390/ph3092861
  54. Lagerberg T., Fazel S., Sjölander A. et al. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study // Neuropsychopharmacology. – 2022. – Vol. 47. – Pp. 817–823. – https://doi.org/10.1038/s41386-021-01179-z
  55. Modarresi A., Chaibakhsh S., Koulaeinejad N., Koupaei S.R. A systematic review and meta-analysis: Memantine augmentation in moderate to severe obsessive-compulsive disorder // Psychiatry research. – 2019. – Vol. 282. – Art. 112602. – https://doi.org/10.1016/j.psychres.2019.112602
  56. Dwyer J.B., Bloch M.H. Antidepressants for pediatric patients // Current Psychiatry. – 2019. – Vol. 18 (9). – Pp. 26–42F.
  57. Цукарзи Э.Э. Современные методы стимуляции мозга: достижения и перспективы применения // Социальная и клиническая психиатрия. – 2013. – Т. 23, № 1. – С. 93–99.
  58. Мосолов С.Н., Цукарзи Э.Э., Маслеников Н.В. Применение транскраниальной магнитной стимуляции в психиатрии / под ред. С.Н. Мосолова. – Иваново: Нейрософт, 2023 576 с.
  59. Mar-Barrutia L., Real E., Segalás C. et al. Deep brain stimulation for obsessive-compulsive disorder: A systematic review of worldwide experience after 20 years // World Journal of Psychiatry. – 2021. – Vol. 11 (9). – Pp. 659–680. – https://doi.org/10.5498/wjp.v11.i9.659
  60. Kim C.H., Chang J.W., Koo M.S. et al. Anterior cingulotomy for refractory obsessive-compulsive disorder // Acta psychiatrica Scandinavica. – 2003. – Vol. 107 (4). – Pp. 283– 290. – https://doi.org/10.1034/j.1600-0447.2003.00087.x
  61. Galkin M.V., Zaitsev O.S., Golanov A.V. et al. Gamma Knife capsulotomy for correction of obsessive-compulsive symptoms in a patient with schizophrenia: Case report // Progress in Brain Research. – 2022. – Vol. 272 (1). – Pp. 23–31. – https://doi.org/10.1016/bs.pbr.2022.03.012
  62. Eddy K.T., Dutra L., Bradley R., Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder // Clinical Psychology Review. – 2004. – Vol. 24 (8). – Pp. 1011–1030. – https://doi.org/10.1016/j.cpr.2004.08.004
  63. Мосолов С.Н., Алфимов П.В. Алгоритм биологической терапии обсессивно-компульсивного расстройства // Современная терапия психических расстройств. – 201 № 1. – C. 41–44.
  64. Усов Г.М. Фармакотерапия обсессивно-компульсивного расстройства: фокус на флувоксамин (обзор литературы) // Психиатрия и психофармакотерапия. – 2020. – № 4. – С. 7–13.

Downloads

Download data is not yet available.